These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Effect of cimetidine and pancreatic enzymes on serum and fecal bile acids and fat absorption in cystic fibrosis. Boyle BJ, Long WB, Balistreri WF, Widzer SJ, Huang N. Gastroenterology; 1980 May; 78(5 Pt 1):950-3. PubMed ID: 7380201 [Abstract] [Full Text] [Related]
31. EUR-1008 pancreatic enzyme replacement is safe and effective in patients with cystic fibrosis and pancreatic insufficiency. Wooldridge JL, Heubi JE, Amaro-Galvez R, Boas SR, Blake KV, Nasr SZ, Chatfield B, McColley SA, Woo MS, Hardy KA, Kravitz RM, Straforini C, Anelli M, Lee C. J Cyst Fibros; 2009 Dec; 8(6):405-17. PubMed ID: 19683970 [Abstract] [Full Text] [Related]
32. Safety and preliminary clinical activity of a novel pancreatic enzyme preparation in pancreatic insufficient cystic fibrosis patients. Borowitz D, Goss CH, Stevens C, Hayes D, Newman L, O'Rourke A, Konstan MW, Wagener J, Moss R, Hendeles L, Orenstein D, Ahrens R, Oermann CM, Aitken ML, Mahl TC, Young KR, Dunitz J, Murray FT. Pancreas; 2006 Apr; 32(3):258-63. PubMed ID: 16628080 [Abstract] [Full Text] [Related]
33. Comparison of two pancreatic enzyme products for exocrine insufficiency in patients with cystic fibrosis. Taylor CJ, Thieroff-Ekerdt R, Shiff S, Magnus L, Fleming R, Gommoll C. J Cyst Fibros; 2016 Sep; 15(5):675-80. PubMed ID: 27013382 [Abstract] [Full Text] [Related]
36. Safety and efficacy of Creon® micro in children with exocrine pancreatic insufficiency due to cystic fibrosis. Kashirskaya NY, Kapranov NI, Sander-Struckmeier S, Kovalev V. J Cyst Fibros; 2015 Mar; 14(2):275-81. PubMed ID: 25066363 [Abstract] [Full Text] [Related]
38. Pancreatic Enzyme Replacement Therapy and Coefficient of Fat Absorption in Children and Adolescents With Cystic Fibrosis. Woestenenk JW, van der Ent CK, Houwen RH. J Pediatr Gastroenterol Nutr; 2015 Sep; 61(3):355-60. PubMed ID: 25782658 [Abstract] [Full Text] [Related]
39. Hyperuricosuria due to high-dose pancreatic extract therapy in cystic fibrosis. Stapleton FB, Kennedy J, Nousia-Arvanitakis S, Linshaw MA. N Engl J Med; 1976 Jul 29; 295(5):246-8. PubMed ID: 934188 [Abstract] [Full Text] [Related]
40. Differences in prevalence and treatment of Pseudomonas aeruginosa in cystic fibrosis centres in Denmark, Norway and Sweden. Knudsen PK, Olesen HV, Høiby N, Johannesson M, Karpati F, Laerum BN, Meyer P, Pressler T, Lindblad A, Scandinavian CF Study Consortium (SCFSC). J Cyst Fibros; 2009 Mar 29; 8(2):135-42. PubMed ID: 19157995 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]